Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BSX
TEVA
Add up to 3 more stocks
BSX
Boston Scientific Corporation
+4.82%
$45.05+2.07Delayed quote: Sep 14, 2026, 4:00 PM EDT
Market Cap
$66.96B
52W Range
$42.20 - $105.65
TEVA
Teva Pharmaceutical Industries Limited
+4.39%
$38.72+1.63Delayed quote: Sep 14, 2026, 4:00 PM EDT
Market Cap
$45.09B
52W Range
$18.21 - $38.37
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 18.31 | 64.53 |
| Forward P/E | 13.70 | 19.48 |
| P/B Ratio | 2.69 | 5.81 |
| P/S Ratio | 3.19 | 2.60 |
| P/FCF Ratio | 18.47 | 33.45 |
| EV/EBITDA | 13.64 | 19.62 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 71.2% | 52.5% |
| Operating Margin | 21.5% | 11.4% |
| Net Margin | 17.5% | 4.1% |
| ROE | 14.7% | 9.1% |
| ROA | 8.1% | 1.8% |
| ROIC | 10.6% | 6.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.24 | 0.88 |
| Quick Ratio | 0.74 | 0.67 |
| Debt/Equity | 0.51 | 2.18 |
| Interest Coverage | 11.38 | 2.35 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.